Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | DRD3 | P35462 | 3/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | PKM | P14618 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | DRD2 | P14416 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27434942 | 1.00 | MAPT (0.36) | MAPTALDH1A1MEN1KMT2ADRD3 | |
| SCHEMBL27434914 | 0.92 | TSHR (0.39) | MAPTALDH1A1DRD3TSHRKDM4E | |
| SCHEMBL27435374 | 0.83 | KCNA3 (0.43) | ALDH1A1MEN1KMT2ADRD3TSHR | |
| SCHEMBL30954054 | 0.83 | KCNA3 (0.43) | ALDH1A1MEN1KMT2ADRD3TSHR | |
| SCHEMBL27435528 | 0.80 | KCNA3 (0.41) | ALDH1A1DRD3TSHRKDM4EHSD17B10 | |
| SCHEMBL27434671 | 0.79 | TP53 (0.40) | ALDH1A1MEN1KMT2AKDM4EHSD17B10 | |
| SCHEMBL30954057 | 0.79 | TP53 (0.40) | ALDH1A1MEN1KMT2AKDM4EHSD17B10 | |
| SCHEMBL27435335 | 0.79 | KDM4E (0.40) | ALDH1A1MEN1KMT2ADRD3KDM4E | |
| SCHEMBL30954160 | 0.79 | KDM4E (0.40) | ALDH1A1MEN1KMT2ADRD3KDM4E | |
| SCHEMBL30954078 | 0.79 | GRM5 (0.33) | ALDH1A1KMT2ADRD3TSHRKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4630412-A1 | COMPOUNDS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS | NMD Pharma A/S (DK) | 2025-10-15 | — | — | EP | claimed |
| WO-2024121130-A1 | COMPOUNDS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS | NMD PHARMA A/S (DK) | 2024-06-13 | — | — | WO | claimed |
| EP-4630412-A1 | COMPOUNDS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS | NMD Pharma A/S (DK) | 2025-10-15 | — | — | EP | disclosed |
| WO-2024121130-A1 | COMPOUNDS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS | NMD PHARMA A/S (DK) | 2024-06-13 | — | — | WO | disclosed |